PBM Company Profile and Key Details

NASDAQ : PBM

Psyence Biomedical

$1.00

-0.46-31.51%

At Close 4:00 PM

$1.00

1.0000-0.17%

Pre-Market 08:30 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Psyence Biomedical Ltd. (PBM) stock declined over -31.51%, trading at $1.00 on NASDAQ, down from the previous close of $1.46. The stock opened at $1.45, fluctuating between $0.97 and $1.47 in the recent session.

Stock Snapshot

1.46

Prev. Close

713.23K

Market Cap

0.97

Day Low

-0.02

P/E Ratio

-62.4

EPS (TTM)

N/A

Cash Flow per Share

1.45

Open

713.23K

Number of Shares

1.47

Day High

100%

Free Float in %

N/A

Book Value

34.65M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 19, 2025	1.44	1.47	0.97	1.00	34.27M
Dec 17, 2025	1.52	1.54	1.44	1.48	110.72K
Dec 16, 2025	1.43	1.53	1.43	1.53	168.33K
Dec 15, 2025	1.48	1.55	1.46	1.48	226.65K
Dec 12, 2025	1.52	1.63	1.49	1.58	329.13K
Dec 11, 2025	1.47	1.59	1.46	1.55	414.15K
Dec 10, 2025	1.57	1.61	1.49	1.53	867.06K
Dec 09, 2025	1.82	1.82	1.45	1.59	15.37M
Dec 08, 2025	1.71	1.77	1.65	1.69	101.36K
Dec 05, 2025	1.81	1.85	1.76	1.76	59.49K
Dec 04, 2025	1.71	1.88	1.71	1.81	196.3K
Dec 03, 2025	1.53	1.86	1.53	1.78	399.84K
Dec 02, 2025	1.62	1.62	1.51	1.58	113.79K
Dec 01, 2025	1.52	1.64	1.48	1.62	208.42K
Nov 28, 2025	1.60	1.60	1.51	1.54	102.94K
Nov 26, 2025	1.46	1.61	1.46	1.58	228.94K
Nov 25, 2025	1.46	1.80	1.41	1.60	571.87K
Nov 24, 2025	1.42	1.55	1.42	1.51	308.35K
Nov 21, 2025	1.55	1.72	1.45	1.49	606.78K
Nov 20, 2025	2.11	2.29	1.58	1.72	20.29M

Contact Details

Toronto, ON M5H2K1

Canada

https://www.psyencebiomed.com 416 346 7764

About Company

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.

Stock Peers

ARGX

7.94+0.94%

argenx SE$854.99 REGN

19.25+2.57%

Regeneron Pharmaceuticals, Inc.$767.96 MDGL

46.61+8.56%

Madrigal Pharmaceuticals, Inc.$591.02 UTHR

10.13+2.00%

United Therapeutics Corporation$517.13 VRTX

8.82+1.97%

Vertex Pharmaceuticals Incorporated$456.20 ALNY

4.19+1.06%

Alnylam Pharmaceuticals, Inc.$400.23 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

3.66001+1.36%

Praxis Precision Medicines, Inc.$272.92 KRYS

7.43+3.18%

Krystal Biotech, Inc.$240.80 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Psyence Biomedical Ltd. (PBM) stock price?

Psyence Biomedical Ltd. (NASDAQ: PBM) stock price is $1.00 in the last trading session. During the trading session, PBM stock reached the peak price of $1.47 while $0.97 was the lowest point it dropped to. The percentage change in PBM stock occurred in the recent session was -31.51% while the dollar amount for the price change in PBM stock was - $0.46.

PBM's industry and sector of operation?

The NASDAQ listed PBM is part of Biotechnology industry that operates in the broader Healthcare sector. Psyence Biomedical Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PBM?

No Data

How PBM did perform over past 52-week?

PBM's closing price is 3.09% higher than its 52-week low of $0.97 where as its distance from 52-week high of $21.20 is -97.06%.

How many employees does PBM have?

Number of PBM employees currently stands at 10.

Link for PBM official website?

Official Website of PBM is: https://www.psyencebiomed.com

How do I contact PBM?

PBM could be contacted at phone 416 346 7764 and can also be accessed through its website. PBM operates from 121 Richmond Street West, Toronto, ON M5H2K1, Canada.

How many shares of PBM are traded daily?

PBM stock volume for the day was 34.65M shares. The average number of PBM shares traded daily for last 3 months was 1.33M.

What is the market cap of PBM currently?

The market value of PBM currently stands at $713.23K with its latest stock price at $1.00 and 713.23K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	10
Beta	0.28
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	10
Beta	0.28
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

PBM Company Profile and Key Details

Psyence Biomedical

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics